Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Submitted by
admin
on May 11, 2023 - 10:55am
Source:
Motley Fool
News Tags:
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
infants
Headline:
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
snippet:
Vertex Pharmaceuticals' cystic fibrosis drugs are extending the lives of child and adult patients.
Now, babies as young as one month old may benefit from one of the company's treatments.
Do Not Allow Advertisers to Use My Personal information